{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T08:15:48Z","timestamp":1768810548853,"version":"3.49.0"},"reference-count":23,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T00:00:00Z","timestamp":1690761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["62025102\/ 81921001"],"award-info":[{"award-number":["62025102\/ 81921001"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Stroke is a major cause of fatalities and disabilities around the world, yet the available treatments for it are still limited. The quest for more efficacious drugs and therapies is still an arduous task. LY2922470 is currently used as a G protein-coupled receptor 40 (GPR40) agonist for the treatment of type 2 diabetes. Previous studies have reported protective effects of other GPR40 activators on the brain; however, it remains unclear whether LY2922470 could be a new stroke therapy and improve the stroke-induced brain damage. Here, we first reveal that the transcriptomic gene signature induced by LY2922470 is highly similar to those induced by some agents being involved in defending from cerebrovascular accidents and transient ischemic attacks, including acetylsalicylic acid, progesterone, estradiol, dipyridamole, and dihydroergotamine. This result thus suggests that LY2922470 could have protective effects against ischemic stroke. As a result, further experiments show that giving the small molecule LY2922470 via oral administration or intraperitoneal injection was seen to have a positive effect on neuroprotection with a reduction in infarct size and an improvement in motor skills in mice. Finally, it was demonstrated that LY2922470 could successfully mitigate the harm to the brain caused by ischemic stroke.<\/jats:p>","DOI":"10.3390\/ijms241512244","type":"journal-article","created":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T09:22:38Z","timestamp":1690795358000},"page":"12244","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["G Protein-Coupled Receptor 40 Agonist LY2922470 Alleviates Ischemic-Stroke-Induced Acute Brain Injury and Functional Alterations in Mice"],"prefix":"10.3390","volume":"24","author":[{"given":"Yingyu","family":"Lu","sequence":"first","affiliation":[{"name":"Department of Biomedical Informatics, State Key Laboratory of Vascular Homeostasis and Remodeling, School of Basic Medical Sciences, Peking University, 38 Xueyuan Rd., Beijing 100191, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanlu","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, State Key Laboratory of Vascular Homeostasis and Remodeling, School of Basic Medical Sciences, Peking University, 38 Xueyuan Rd., Beijing 100191, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinghua","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, State Key Laboratory of Vascular Homeostasis and Remodeling, School of Basic Medical Sciences, Peking University, 38 Xueyuan Rd., Beijing 100191, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6223-5225","authenticated-orcid":false,"given":"Chunmei","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, State Key Laboratory of Vascular Homeostasis and Remodeling, School of Basic Medical Sciences, Peking University, 38 Xueyuan Rd., Beijing 100191, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,7,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/nature06797","article-title":"Triggers, targets and treatments for thrombosis","volume":"451","author":"Mackman","year":"2008","journal-title":"Nature"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1161\/CIRCRESAHA.121.318322","article-title":"Epidemiology and Genetics of Venous Thromboembolism and Chronic Venous Disease","volume":"128","author":"Baylis","year":"2021","journal-title":"Circ. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41572-019-0118-8","article-title":"Ischaemic stroke","volume":"5","author":"Campbell","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1161\/CIR.0000000000000558","article-title":"Heart disease and stroke statistics-2018 update: A report from the American Heart Association","volume":"137","author":"Benjamin","year":"2018","journal-title":"Circulation"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1161\/STR.0000000000000158","article-title":"2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association\/American Stroke Association","volume":"49","author":"Powers","year":"2018","journal-title":"Stroke"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nrcardio.2015.83","article-title":"Epidemiology of venous thromboembolism","volume":"12","author":"Heit","year":"2015","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.1111\/ejn.15224","article-title":"Stroke and immunotherapy: Potential mechanisms and its implications as immune-therapeutics","volume":"54","author":"Chavda","year":"2021","journal-title":"Eur. J. Neurosci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1161\/CIRCRESAHA.116.309278","article-title":"Acute Ischemic Stroke Therapy Overview","volume":"120","author":"Catanese","year":"2017","journal-title":"Circ. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.jacc.2020.03.006","article-title":"Hyperacute Management of Ischemic Strokes: JACC Focus Seminar","volume":"75","author":"Patel","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41419-023-05581-x","article-title":"Crocetin antagonizes parthanatos in ischemic stroke via inhibiting NOX2 and preserving mitochondrial hexokinase-I","volume":"14","author":"Wu","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nrn3214","article-title":"The economy of brain network organization","volume":"13","author":"Bullmore","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0165-0173(00)00038-2","article-title":"CNS energy metabolism as related to function","volume":"34","author":"Ames","year":"2000","journal-title":"Brain Res. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"174183","DOI":"10.1016\/j.ejphar.2021.174183","article-title":"Methyl palmitate protects heart against ischemia\/reperfusion-induced injury through G-protein coupled receptor 40-mediated activation of the PI3K\/AKT pathway","volume":"905","author":"Shen","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-021-02209-9","article-title":"Activation of GPR40 attenuates neuroinflammation and improves neurological function via PAK4\/CREB\/KDM6B pathway in an experimental GMH rat model","volume":"18","author":"Xiao","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1007\/s11064-018-2587-7","article-title":"Lauric Acid Alleviates Neuroinflammatory Responses by Activated Microglia: Involvement of the GPR40-Dependent Pathway","volume":"43","author":"Nishimura","year":"2018","journal-title":"Neurochem. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"10891","DOI":"10.1021\/acs.jmedchem.6b00892","article-title":"The Discovery, Preclinical, and Early Clinical Development of Potent and Selective GPR40 Agonists for the Treatment of Type 2 Diabetes Mellitus (LY2881835, LY2922083, and LY2922470)","volume":"59","author":"Hamdouchi","year":"2016","journal-title":"J. Med. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1080\/13543784.2016.1189530","article-title":"Free fatty acid receptor agonists for the treatment of type 2 diabetes: Drugs in preclinical to phase II clinical development","volume":"25","author":"Li","year":"2016","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"506","DOI":"10.4093\/dmj.2021.0092","article-title":"GPR40 Agonism Modulates Inflammatory Reactions in Vascular Endothelial Cells","volume":"46","author":"Kim","year":"2022","journal-title":"Diabetes Metab. J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1021\/ml1000855","article-title":"Discovery of TAK-875: A Potent, Selective, and Orally Bioavailable GPR40 Agonist","volume":"1","author":"Negoro","year":"2010","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1126\/science.1132939","article-title":"The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease","volume":"313","author":"Lamb","year":"2006","journal-title":"Science"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Kiepura, A., Stachyra, K., and Olszanecki, R. (2021). Anti-Atherosclerotic Potential of Free Fatty Acid Receptor 4 (FFAR4). Biomedicines, 9.","DOI":"10.3390\/biomedicines9050467"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"117133","DOI":"10.1016\/j.lfs.2019.117133","article-title":"Eicosapentaenoic acid prevents inflammation induced by acute cerebral infarction through inhibition of NLRP3 inflammasome activation","volume":"242","author":"Mo","year":"2019","journal-title":"Life Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.molmet.2014.10.002","article-title":"GPR40 (FFAR1) \u2013 Combined Gs and Gq signaling in vitro is associated with robust incretin secretagogue action ex vivo and in vivo","volume":"4","author":"Hauge","year":"2015","journal-title":"Mol. Metab."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/15\/12244\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:23:05Z","timestamp":1760127785000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/15\/12244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,31]]},"references-count":23,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["ijms241512244"],"URL":"https:\/\/doi.org\/10.3390\/ijms241512244","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,31]]}}}